| Literature DB >> 32159046 |
Sheena E Martenies1, Ali Akherati2, Shantanu Jathar2, Sheryl Magzamen1,3.
Abstract
Despite improvements in air quality over the past 50 years, ambient air pollution remains an important public health issue in the United States. In particular, emissions from coal-fired power plants still have a substantial impact on both nearby and regional populations. Of particular concern is the potential for this impact to fall disproportionately on low-income communities and communities of color. We conducted a quantitative health impact assessment to estimate the health benefits of the proposed decommissioning of two coal-fired electricity generating stations in the Southern Front Range region of Colorado. We estimated changes in exposures to fine particulate matter and ozone using the Community Multiscale Air Quality model and predicted avoided health impacts and related economic values. We also quantitatively assessed the distribution of these benefits by population-level socioeconomic status. Across the study area, decommissioning the power plants would result in 2 (95% CI: 1-3) avoided premature deaths each year due to reduced PM2.5 exposures and greater reductions in hospitalizations and other morbidities. Health benefits resulting from the modeled shutdowns were greatest in areas with lower educational attainment and other economic indicators. Our results suggest that decommissioning these power plants and replacing them with zero-emissions sources could have broad public health benefits for residents of Colorado, with larger benefits for those that are socially disadvantaged. Our results also suggested that researchers and decision makers need to consider the unique demographics of their study areas to ensure that important opportunities to reduce health disparities associated with point-source pollution. ©2019. The Authors.Entities:
Keywords: ambient air pollution; community multiscale air quality model; economic assessment; environmental justice; health impact assessment; inequality metrics
Year: 2019 PMID: 32159046 PMCID: PMC7007175 DOI: 10.1029/2019GH000206
Source DB: PubMed Journal: Geohealth ISSN: 2471-1403
Figure 1Map of the subset of the study area showing the location of the power plants and the included ZCTAs in the southern Front Range region of Colorado. ZTAs = ZIP Code Tabulation Areas.
Summary of the Health Benefits Scenarios Used in This HIA
| Scenario name | Baseline exposure scenario | Post‐shutdown exposures |
|---|---|---|
| Health Benefits Scenario 1 | Model Run 1: CMAQ was run for representative summer and winter periods using the 2011 NEI for emissions at all sources in the area except Martin Drake. For Martin Drake, we adjusted the 2011 NEI emissions to account for scrubbers installed in 2016. | Model Run 3: CMAQ was run for representative summer and winter periods using the 2011 NEI for emissions at all sources in the area except Comanche Units 1 and 2 and Martin Drake Units 5, 7, and 8, which were “zeroed out.” |
| Health Benefits Scenario 2 | Model Run 2: CMAQ was run for representative summer and winter periods using the 2011 NEI for emissions at all sources in the area without adjustments for the scrubbers installed at Martin Drake. | Model Run 3: CMAQ was run for representative summer and winter periods using the 2011 NEI for emissions at all sources in the area except Comanche Units 1 and 2 and Martin Drake Units 5, 7, and 8, which were “zeroed out.” |
Summary Statistics for the Change in Population‐Weighted Exposures to PM2.5 (μg/m3) and ozone (ppbv) Across All ZCTAs in Colorado for Health Benefits Scenario 1, Which Compared Concentrations Based on a Counterfactual 2016 Baseline Emissions to a Full Shutdown at Martin Drake and Partial Shutdown at Comanche
| Pollutant | Season | Metric | Mean (SD) | Min | Median | Max |
|---|---|---|---|---|---|---|
| PM2.5 | Winter | Monthly mean | −0.005 (0.010) | −0.082 | −0.001 | 0.000 |
| Winter | Daily mean | −0.004 (0.015) | −0.259 | 0.000 | 0.015 | |
| Summer | Monthly mean | −0.006 (0.012) | −0.098 | −0.003 | 0.000 | |
| Summer | Daily mean | −0.006 (0.015) | −0.259 | −0.001 | 0.006 | |
| O3 | Winter | Monthly mean | 0.017 (0.036) | −0.003 | 0.003 | 0.201 |
| Winter | Daily mean | 0.017 (0.068) | −0.131 | 0.000 | 1.115 | |
| Winter | Daily 1‐hr max | −0.011 (0.046) | −0.645 | 0.000 | 0.316 | |
| Winter | Daily 8‐hr max | −0.003 (0.024) | −0.375 | 0.000 | 0.381 | |
| Summer | Monthly mean | −0.025 (0.033) | −0.111 | −0.027 | 0.226 | |
| Summer | Daily mean | −0.024 (0.080) | −0.696 | −0.006 | 1.214 | |
| Summer | Daily 1‐hr max | −0.182 (0.351) | −5.248 | −0.049 | 0.140 | |
| Summer | Daily 8‐hr max | −0.088 (0.155) | −1.876 | −0.030 | 0.140 |
Note. SD = standard deviation
Figure 2Changes in mean summer PM2.5 (a; μg/m3) and O3 (b; ppb) concentrations at the ZIP Code Tabulation Area level for Health Benefits Scenario 1.
Summary of Annual and Accrued Health Benefits (through 2035) as the Median Number of Avoided Premature Deaths and Cases of Morbidity (2.5th to 97.5th Percentiles) Across the Study Area and for Each Subsection of the Study Area for Health Benefits Scenario 1
| All ZCTAs | SFR | Colorado Springs | Pueblo | ||
|---|---|---|---|---|---|
| Outcome | Benefits per year | ||||
| PM2.5 | AC mortality | 2 (1, 3) | 1 (1, 2) | 1 (1, 1) | 0 (0, 0) |
| CVD hospitalization | 0 (0, 1) | 0 (0, 1) | 0 (0, 0) | 0 (0, 0) | |
| RES hospitalization | 0 (0, 1) | 0 (0, 1) | 0 (0, 0) | 0 (0, 0) | |
| ED visit for asthma | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | |
| AST symptom day | 2 (−17, 44) | 1 (−11, 27) | 1 (−8, 20) | 0 (−2, 5) | |
| MRAD | 28 (−2, 200) | 23 (2, 100) | 19 (2, 74) | 3 (0, 17) | |
| Work loss day | 5 (0, 32) | 4 (0, 17) | 3 (0, 12) | 1 (0, 3) | |
| O3 | NA mortality | 0 (0, 1) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) |
| RES hospitalization | 1 (−11, 22) | 0 (−9, 6) | 0 (−5, 3) | 0 (−4, 2) | |
| ED visit for asthma | 0 (0,0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | |
| AST symptom day | 10 (−220, 790) | 6 (−110, 270) | 4 (−63, 170) | 1 (−28, 57) | |
| MRAD | 53 (−17, 590) | 23 (−15, 170) | 14 (−7, 100) | 6 (−6, 34) | |
| School absence day | 60 (−54, 970) | 29 (−35, 300) | 18 (−17, 170) | 7 (−13, 62) | |
| Accrued benefits through 2035 | |||||
| PM2.5 | AC mortality | 38 (19, 57) | 19 (9, 38) | 19 (9, 38) | 0 (0, 0) |
| CVD hospitalization | 0 (0, 19) | 0 (0, 19) | 0 (0, 0) | 0 (0, 0) | |
| RES hospitalization | 0 (0, 19) | 0 (0, 19) | 0 (0, 0) | 0 (0, 0) | |
| ED visit for asthma | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | |
| AST symptom day | 38 (−320, 840) | 19 (−210, 510) | 19 (−152, 380) | 0 (−38, 95) | |
| MRAD | 530 (−38, 3,700) | 440 (38, 1,900) | 360 (38, 1,400) | 57 (0, 323) | |
| Work loss day | 95 (0, 610) | 76 (0, 320) | 57 (0, 230) | 19 (0, 57) | |
| O3 | NA mortality | 0 (0, 19) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) |
| RES hospitalization | 19 (−210, 420) | 0 (−170, 110) | 0 (−95, 57) | 0 (−76, 38) | |
| ED visit for asthma | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | |
| AST symptom day | 190 (−5,300, 15,000) | 110 (−2,100, 5,100) | 76 (−1,200, 3,100) | 19 (−530, 1,100) | |
| MRAD | 1,000 (−320, 11,000) | 440 (−290, 3,300) | 270 (−130, 2,000) | 110 (−110, 650) | |
| School absence day | 1,100 (−1,000, 18,000) | 550 (−670, 5,700) | 340 (−320, 3,500) | 130 (−250, 1,200) | |
Note. Values have been rounded to two significant figures. AC = all‐cause; AST = asthma; ED = emergency department; MRAD = minor‐restricted activity day; NA = non accidental; RES = respiratory; SFR = Southern Front Range.
Summary of Total Monetized Value of Annual and Accrued Health Benefits (Through 2035) in $1,000s (2.5th to 97.5th Percentiles) Across the Study Area and for Each Subsection of the Study Area for Health Benefits Scenario 1
| All ZCTAs | SFR | Colorado Springs | Pueblo | ||
|---|---|---|---|---|---|
| Outcome | Monetized benefits per year | ||||
| PM2.5 | AC mortality | 17,000 (10,000, 26,000) | 13,000 (7,700, 20,000) | 9,400 (5,500, 14,000) | 2,800 (1,700, 4,000) |
| CVD hospitalization | 7 (0, 46) | 6 (0, 26) | 4 (0, 17) | 1 (0, 7) | |
| RES hospitalization | 4 (‐1, 39) | 4 (0, 22) | 3 (0, 15) | 1 (0, 6) | |
| ED visit for asthma | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | |
| AST symptom day | 0 (−1, 3) | 0 (−1, 2) | 0 (−1, 1) | 0 (0, 0) | |
| MRAD | 2 (0, 13) | 2 (0, 7) | 1 (0, 5) | 0 (0, 1) | |
| Work loss day | 1 (0, 5) | 1 (0, 3) | 0 (0, 2) | 0 (0, 0) | |
| O3 | NA mortality | 440 (−1,600, 5,800) | 180 (−1,400, 2,200) | 54 (−760, 1,100) | 83 (−520, 710) |
| RES hospitalization | 24 (−400, 830) | −4 (−340, 240) | −8 (−180, 110) | 2 (−150, 82) | |
| ED visit for asthma | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | |
| AST symptom day | 1 (−17, 47) | 0 (−7, 16) | 0 (−4, 10) | 0 (−2, 3) | |
| MRAD | 4 (−1, 40) | 2 (−1, 12) | 1 (0, 7) | 0 (0, 2) | |
| School absence day | 6 (−5, 95) | 3 (−3, 30) | 2 (−2, 18) | 1 (−1, 6) | |
| Accrued monetized benefits through 2035 | |||||
| PM2.5 | AC mortality | 270,000 (160,000, 400,000) | 200,000 (120,000, 300,000) | 140,000 (85,000, 220,000) | 43,000 (27,000, 62,000) |
| CVD hospitalization | 100 (−4, 710) | 88 (8, 400) | 68 (7, 260) | 18 (0, 100) | |
| RES hospitalization | 68 (−13, 600) | 58 (−4, 340) | 44 (−3, 220) | 13 (−1, 98) | |
| ED visit for asthma | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | |
| AST symptom day | 1 (−16, 41) | 1 (−10, 25) | 1 (−8, 18) | 0 (−2, 4) | |
| MRAD | 29 (−2, 200) | 24 (2, 110) | 20 (2, 77) | 3 (0, 18) | |
| Work loss day | 11 (−1, 74) | 9 (1, 39) | 7 (1, 28) | 1 (0, 7) | |
| O3 | NA mortality | 6,700 (−25,000, 90,000) | 2,700 (−21,000, 34,000) | 830 (−12,000, 16,000) | 1,300 (−8,000, 11,000) |
| RES hospitalization | 370 (−6,200, 13,000) | −61 (−5,300, 3,600) | −130 (−2,700, 1,700) | 27 (−2,300, 1300) | |
| ED visit for asthma | 0 (0, 2) | 0 (0, 1) | 0 (0, 0) | 0 (0, 0) | |
| AST symptom day | 9 (−260, 720) | 5 (−100, 250) | 3 (−58, 150) | 1 (−26, 52) | |
| MRAD | 56 (−18, 610) | 24 (−15, 180) | 15 (−7, 110) | 6 (−6, 36) | |
| School absence day | 90 (−81, 1,500) | 43 (−52, 450) | 27 (−26, 280) | 11 (−19, 93) | |
| Total | 270,000 (130,000, 510,000) | 200,000 (91,000, 340,000) | 140,000 (70,000, 240,000) | 44,000 (16,00, 74,000) | |
Note. Monetized values are reported as 2011$ projected to a 2024 income level following methods reported by U.S. EPA (U.S. Environmental Protection Agency [US EPA], 2015a). Accrued benefits are discounted at a 3% rate. Values have been rounded to two significant figures. AC = all‐cause; AST = asthma; ED = emergency department; MRAD = minor‐restricted activity day; NA = nonaccidental; RES = respiratory.
Figure 3The percentage of ZIP Code Tabulation Area populations that are non‐Hispanic White (a) and median income (b) and benefits of reducing emission (Health Benefits Scenario 1) as avoided deaths attributable to PM2.5 (c) and O3 (d) ZCTAs near the Martin Drake power plant in Colorado Springs, CO.
Figure 4The percentage of ZIP Code Tabulation Area populations that are non‐Hispanic White (a) and median income (b) and annual benefits of reducing emission (Health Benefits Scenario 1) as avoided deaths attributable to PM2.5 (c) and O3 (d) ZCTAs near the Comanche power plant in Pueblo, CO.
Figure 5Concentration curves for rates of avoided deaths (per 10,000 persons) resulting from reduced PM2.5 (a) or O3 (b) exposures under Health Benefits Scenario 1 when ranking ZCTAs by indicators of social advantage. ZTAs = ZIP Code Tabulation Areas.